Valerie is Teva Pharmaceutical’s Vice President, Global Regulatory CMC and Growth Markets RA, with responsibility for Teva’s Branded Products portfolio, encompasses both small molecules and biologicals, including biosimilars. Valerie’s career spans over 30 years in pharmaceuticals, biologics and devices, and includes both large and small cap companies. Valerie has been responsible for Analytical R&D, QC, QA, QA Engineering, Clinical Development and Regulatory Affairs functions. Valerie started her career at Bristol-Myers Squibb in Ireland, and then relocated to the US when she joined J&J (McNeil Specialty & later Ethicon), followed by Neose Technologies. In 2010, Valerie joined Teva Pharmaceuticals and she is currently based in Frazer, PA.